CG Oncology, Inc.

SecurityCGON / CG Oncology, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership172,815 shares
Latest Disclosed Value $ 11,696,119
Citadel Advisors Llc ownership in CGON / CG Oncology, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 172,815 shares of CG Oncology, Inc. (US:CGON) valued at $11,696,119 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 681,186 shares of CG Oncology, Inc.. This represents a change in shares of -74.63% during the quarter. The current value of the position is $9,404,592 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (CGON) in the form of stock options. The firm currently holds call options representing 58,300 of underlying shares valued at $3,945,744 USD and put options representing 36,700 of underlying shares valued at $2,483,856 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CGON / CG Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CG ONCOLOGY COM 156944100 172,815 -508,371 -74.63 11,696 -58.65 0.0019
2026-02-17 2025-12-31 13F CG ONCOLOGY COM 156944100 681,186 442,414 185.29 28,283 194.08 0.0042
2025-11-14 2025-09-30 13F CG ONCOLOGY COM 156944100 238,772 63,519 36.24 9,618 111.08 0.0015
2025-08-14 2025-06-30 13F CG ONCOLOGY COM 156944100 175,253 -963,665 -84.61 4,557 -83.67 0.0008
2025-05-15 2025-03-31 13F CG ONCOLOGY COM 156944100 1,138,918 -30,335 -2.59 27,892 -16.82 0.0053
2025-02-14 2024-12-31 13F CG ONCOLOGY COM 156944100 1,169,253 847,890 263.84 33,534 176.57 0.0058
2024-11-14 2024-09-30 13F CG ONCOLOGY COM 156944100 321,363 -170,331 -34.64 12,125 -21.89 0.0023
2024-08-14 2024-06-30 13F CG ONCOLOGY COM 156944100 491,694 215,233 77.85 15,523 27.90 0.0031
2024-05-15 2024-03-31 13F CG ONCOLOGY COM 156944100 276,461 276,461 12,137 0.0023
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CG ONCOLOGY COM Call 58,300 -3.32 3,946 57.61 n/a n/a n/a
2026-02-17 2025-12-31 13F CG ONCOLOGY COM Call 60,300 169.20 2,504 177.49 n/a n/a n/a
2025-11-14 2025-09-30 13F CG ONCOLOGY COM Call 22,400 -55.73 902 -31.41 n/a n/a n/a
2025-08-14 2025-06-30 13F CG ONCOLOGY COM Call 50,600 1,774.07 1,316 1,892.42 n/a n/a n/a
2025-05-15 2025-03-31 13F CG ONCOLOGY COM Call 2,700 -82.24 66 -84.83 n/a n/a n/a
2025-02-14 2024-12-31 13F CG ONCOLOGY COM Call 15,200 436 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CG ONCOLOGY COM Put 36,700 0.82 2,484 64.33 n/a n/a n/a
2026-02-17 2025-12-31 13F CG ONCOLOGY COM Put 36,400 451.52 1,511 470.19 n/a n/a n/a
2025-11-14 2025-09-30 13F CG ONCOLOGY COM Put 6,600 -81.82 266 -71.90 n/a n/a n/a
2025-08-14 2025-06-30 13F CG ONCOLOGY COM Put 36,300 15.24 944 22.31 n/a n/a n/a
2025-05-15 2025-03-31 13F CG ONCOLOGY COM Put 31,500 -8.70 771 -22.04 n/a n/a n/a
2025-02-14 2024-12-31 13F CG ONCOLOGY COM Put 34,500 70.79 989 29.79 n/a n/a n/a
2024-11-14 2024-09-30 13F CG ONCOLOGY COM Put 20,200 23.93 762 48.25 n/a n/a n/a
2024-08-14 2024-06-30 13F CG ONCOLOGY COM Put 16,300 715.00 515 490.80 n/a n/a n/a
2024-05-15 2024-03-31 13F CG ONCOLOGY COM Put 2,000 88 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.